Extracardiac birth defects in children with congenital heart defects

Sunil Karande1, Varsha Patil, Archana Kher

  • 1Genetic Clinic, Department of Pediatrics, Seth GS Medical College and KEM Hospital, Parel, Mumbai, India. Correspondence to: Dr Sunil Karande, Professor, Department of Pediatrics, Seth GS Medical College and KEM Hospital, Parel, Mumbai 400 012, India. karandesunil@yahoo.com.

Indian Pediatrics
|June 24, 2014
PubMed

Insights

Extracardiac birth defects are common in children with congenital heart defects (CHDs). This study found that 17.5% of children with CHDs had these additional defects, with craniofacial and skeletal issues being most frequent.

Area of Science:

  • Pediatric Cardiology
  • Medical Genetics
  • Developmental Biology

Background:

  • Congenital heart defects (CHDs) are a significant cause of infant mortality and morbidity.
  • Extracardiac birth defects (ECBDs) can complicate the management and outcomes of children with CHDs.
  • Understanding the prevalence and patterns of ECBDs is crucial for comprehensive care.

Purpose of the Study:

  • To determine the frequency and types of extracardiac birth defects in children diagnosed with congenital heart defects.
  • To analyze the pattern of these associated defects in a tertiary care setting.

Main Methods:

  • A cross-sectional observational study was conducted.
  • Data was collected from January 2010 to June 2011.
  • Included 560 children with congenital heart defects.

Main Results:

  • Nearly one-fifth (17.5%) of children with CHDs presented with extracardiac birth defects.
  • A total of 386 ECBDs were identified, comprising 103 major and 283 minor defects.
  • Craniofacial and skeletal anomalies were the most prevalent types of ECBDs, with 36 cases of syndromic conditions and 6 with laterality defects.

Conclusions:

  • Extracardiac birth defects are a frequent comorbidity in pediatric patients with congenital heart defects.
  • The findings highlight the importance of thorough screening for ECBDs in children with CHDs.
  • Early identification and management of ECBDs can improve patient outcomes.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
3.9K
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
684
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
813
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
5.0K